Skip to main content
Log in

Commentary

  • Published:
Breast Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

o|

  1. Ragaz J, Jackson SM, Plenderleith IHet al: Adjuvant radiotherapy and chemotherapy in node-positive pre-menopausal women with breast cancer.N Engl J Med 337: 956–962, 1997.

    Article  PubMed  CAS  Google Scholar 

  2. Overgaard M, Hansen PS, Overgaard J,et al: Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy.N Eng J Med 337: 949–955, 1997.

    Article  CAS  Google Scholar 

  3. Overgaard M, Jensen M-B, Overgaard J,et al: Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG82c randomised trial.Lancet 353: 1641–1648, 1999.

    Article  PubMed  CAS  Google Scholar 

  4. Fisher B, Redmond C, Fisher ER,et al: Ten-year results of randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation.N Engl J Med 312: 674–681, 1982.

    Google Scholar 

  5. Hellman S: Stopping metastases at their source.N Engl J Med 337: 996–997, 1997.

    Article  PubMed  CAS  Google Scholar 

  6. Kaufmann M, Jona W, Abel U,et al: Adjuvant randomized trials of doxorubicin/cyclophosphamide versus doxorubicin/cyclophosphamide/tamoxifen and CMF chemotherapy versus tamoxifen in women with nodepositive breast cancer.J clin Oncol 11: 454–460, 1993.

    PubMed  CAS  Google Scholar 

  7. Buzder A, McNeese MD, Hortobagyi GN,et al: Is chemotherapy effective in reducing the local failure rate in patients with operable breast cancer?Cancer 65: 394-399, 1990.Is chemotherapy effective in reducing the local failure rate in patients with operable breast cancer?Cancer 65: 394–399, 1990.

    Google Scholar 

  8. Goldhirsch A, Gelber RD, Castiglione M: Relapse of breast cancer after adjuvant treatment in premenopausal and premenopausal women: patterns and prognoses.J Clin Oncol 6: 89–97, 1988.

    PubMed  CAS  Google Scholar 

  9. Chu AM, Kiel K: Comparison of adjuvant postoperative radiotherapy and multiple-drug chemotherapy (CMF-VP) in operable breast cancer patients with more than four positive axillary lymph nodes.Cancer 50: 212–218, 1982.

    Article  PubMed  CAS  Google Scholar 

  10. Velez-Garcia E, Carpenter JT, Moore M,et al: Postsurgical adjuvant chemotherapy with or without radiotherapy in women with breast cancer and positive axillary nodes: A South- Eastern Stdy Group (SEG) trial.Eur J Cancer 28A: 1833–1837, 1992.

    Article  PubMed  CAS  Google Scholar 

  11. Recht A, Gray R, Davidson NE,et al: Locoregional failure ten years after mastectomy and adjuvaht chemotherapy with or without tamoxifen without irradiation: Experince of the Eastern Cooperative Oncology Group.J Clin Oncol 17: 1689–1700, 1999.

    PubMed  CAS  Google Scholar 

  12. Recht A: Postmastectomy locoregional radiotherapy: Is it here to stay?Semin Oncol 28: 245–252, 2001.

    Article  PubMed  CAS  Google Scholar 

  13. Khayat D, Antoine EC, Nizri D,et al: Neoadjuvant chemotherapy in breast Cancer: Simple prognostic or useful predictive factor? Educ. Book ASCO: 510–515, 2001.

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

Khayat, D., Aloro, G.C. Commentary. Breast Cancer 9, 6–7 (2002). https://doi.org/10.1007/BF02967539

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02967539

Navigation